Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

3 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(45.5%)
Phase 4
2(18.2%)
Phase 2
2(18.2%)
Phase 1
1(9.1%)
Phase 3
1(9.1%)
11Total
N/A(5)
Phase 4(2)
Phase 2(2)
Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)